Química médica y biológica - MedChemLab
QUÍMICA MÉDICA
Universidade de Santiago de Compostela
Santiago de Compostela, EspañaPublicaciones en colaboración con investigadores/as de Universidade de Santiago de Compostela (6)
2022
-
2-(Fluoromethoxy)-4′-(S-methanesulfonimidoyl)-1,1′-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D1Receptor for Parkinson's Disease
Journal of Medicinal Chemistry, Vol. 65, Núm. 18, pp. 12256-12272
-
Discovery of V-0219: A Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor toward Oral Treatment for "diabesity"
Journal of Medicinal Chemistry, Vol. 65, Núm. 7, pp. 5449-5461
2019
-
Glycosylated Cell-Penetrating Peptides (GCPPs)
ChemBioChem, Vol. 20, Núm. 11, pp. 1400-1409
2006
-
Determination of the bound conformation of a competitive nanomolar inhibitor of Mycobacterium tuberculosis type II dehydroquinase by NMR spectroscopy
ChemMedChem, Vol. 1, Núm. 9, pp. 990-996
-
Enhanced signal dispersion in saturation transfer difference experiments by conversion to a 1D-STD-homodecoupled spectrum
Journal of Biomolecular NMR, Vol. 36, Núm. 2, pp. 103-109
2003
-
NMR experiments for the measurement of proton-proton and carbon-carbon residual dipolar couplings in uniformly labelled oligosaccharides
Journal of Biomolecular NMR, Vol. 26, Núm. 4, pp. 345-353